Companies / South Korea
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Bukwang Launches New Hepatitis Drug
November 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
South Korean drugmaker Bukwang Pharmaceutical has received the green light from the Korean Food & Drug Administration (KFDA) for its new Hepatitis B treatment, Levovir. The drug has taken over ten years to develop and is reported to be the eleventh innovative medicine produced by Korea's pharmaceutical R&D sector.